feed,title,long_url,short_url
MedRxiv,Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children,https://medrxiv.org/cgi/content/short/2022.03.03.22271313v1?rss=1,https://bit.ly/34h6VQy
